Benzodiazepines and Therapeutic Counselling

1 Introduction.- 1.1 Review of the Mental Health Programme of the World Health Organization (WHO).- 1.2 Related Efforts of the Organization.- 1.3 Reasons for Undertaking a Study Using Benzodiazepines.- 1.4 Acknowledgement.- 2 Literature Review.- 2.1 Literature on Cross-Cultural Comparisons of Effectiveness of Psychotropic Drugs.- 2.2 Literature on Cross-Cultural Comparisons of Psychotherapy.- 2.3 Literature on Methodological Issues Involved in the Conduct of Comparative Studies.- 2.4 Literature About Administrative/Procedural Aspects of Multicentric Trials.- 3 Aims of the Study.- 4 Description of Materials and Methods.- 4.1 Design of the Study.- 4.2 Description of Centres at Which the Study Took Place.- 4.3 Description of Samples and Manner of Selection.- 4.4 Description of Instruments Used for Assessment and Training of Research Workers.- 4.5 Treatments.- 5 Results.- 5.1 Assessment of the Value of Instruments Used.- 5.2 Overall Comparisons Among Centres.- 5.3 Within-Centre Comparisons (Between Methods and Treatments).- 5.4 GHQ Factor Scores, Weeks 0 to 2 to 6.- 5.5 Comparison of Scores on Present State Examination.- 5.6 Treatment-Emergent Symptoms.- 5.7 Physical Measurements.- 5.8 Brief Life Events Questionnaire.- 5.9 General Summary: Effects of Drugs and Counselling.- 6 Results: Analysis of Counselling.- 6.1 Difference Among Centres in Amount of Counselling.- 6.2 Differences Among Centres in Methods of Counselling.- 6.3 Problem Areas Considered at Interview.- 6.4 Final Audit of Counselling.- 7 Discussion.- 7.1 Indirect Evaluation of Treatments.- 7.2 Evaluation of Treatments with Scales.- 7.3 General Improvement.- 7.4 Effects of the Study on Participating Centres.- 7.5 Methodological Limitations.- 7.6 Further Work.- 8 Conclusions.- References.- Appendix A: Descriptionof Research Centres and Study Areas.- Appendix B: Data Collection Forms.